A phase IIIB, randomized, trial of open-label non-nucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI) with another PI in combination with double-blind comparison of two nucleoside reverse transcriptase inhibitors (NRTI) or a different NRTI in antiretroviral-naive subjects
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2006
At a glance
- Drugs HIV protease inhibitors; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Oct 2006 New trial record.